Oramed Pharmaceuticals
ORMP
#8952
Rank
โ‚น12.32 B
Marketcap
โ‚น309.42
Share price
-1.44%
Change (1 day)
50.68%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2025 (TTM): โ‚น5.18 Billion

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are โ‚น2 Million. In 2024 the company made an earning of -โ‚น1.36 Billion a decrease over its 2023 earnings that were of โ‚น0.64 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น5.18 B-481.37%
2024 -โ‚น1.36 Billion-311.47%
2023 โ‚น0.64 B-119.45%
2022 -โ‚น3.31 Billion39.17%
2021 -โ‚น2.38 Billion73.93%
2020 -โ‚น1.37 Billion18.53%
2019 -โ‚น1.16 Billion-16.62%
2018 -โ‚น1.39 Billion38.32%
2017 -โ‚น1 Billion12.51%
2016 -โ‚น0.89 Billion25.01%
2015 -โ‚น0.71 Billion18.18%
2014 -โ‚น0.61 Billion39.72%
2013 -โ‚น0.43 Billion46.4%
2012 -โ‚น0.3 Billion128.32%
2011 -โ‚น0.13 Billion-51.47%
2010 -โ‚น0.27 Billion35.21%
2009 -โ‚น0.2 Billion
2007 -โ‚น0.31 Billion607.04%
2006 -โ‚น43.6 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-โ‚น46.79 Billion-989.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
โ‚น1.880 T 35,654.86%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
โ‚น820.94 B 15,508.83%๐Ÿ‡ซ๐Ÿ‡ท France
Compugen
CGEN
-โ‚น2.49 Billion-147.27%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Lexicon Pharmaceuticals
LXRX
-โ‚น6.19 Billion-217.63%๐Ÿ‡บ๐Ÿ‡ธ USA